SFlt-1 is a protein that acts as an antagonist to PlGF (which promotes angiogenesis). Therefore, sFlt-1 reduces angiogenesis and is known as an anti-angiogenic factor. Quantitative testing of sFlt-1 (in combination with PlGF) is often indicated in the early diagnosis and differential diagnosis of preeclampsia.